TC BioPharm Announces Annual General Meeting for August 2025

TC Biopharm (Holdings) ( (TCBPY) ) has shared an update.

On August 5, 2025, TC BioPharm (Holdings) plc announced the details of its upcoming Annual General Meeting (AGM) scheduled for August 29, 2025. The meeting will be held physically at the company’s headquarters in Scotland, and shareholders are encouraged to vote on various resolutions, including the re-appointment of auditors and the approval of financial statements. The announcement highlights the importance of shareholder participation and outlines the voting process for both ordinary shareholders and holders of American Depositary Shares (ADSs). The resolutions proposed are deemed to be in the best interests of the company and its shareholders, aiming to promote the company’s success.

The most recent analyst rating on (TCBPY) stock is a Buy with a $3.00 price target. To see the full list of analyst forecasts on TC Biopharm (Holdings) stock, see the TCBPY Stock Forecast page.

Spark’s Take on TCBPY Stock

According to Spark, TipRanks’ AI Analyst, TCBPY is a Underperform.

TC Biopharm’s overall score is primarily impacted by its weak financial performance, characterized by declining revenues and negative cash flow. Technical analysis indicates bearish momentum, while the absence of valuation metrics and earnings call information limits positive insights. The stock’s financial instability and operational inefficiencies are major concerns.

To see Spark’s full report on TCBPY stock, click here.

More about TC Biopharm (Holdings)

TC BioPharm (Holdings) plc is a biotechnology company based in Scotland, United Kingdom. The company focuses on developing innovative cell-based therapies for the treatment of cancer and other serious diseases.

Average Trading Volume: 8,113

Technical Sentiment Signal: Sell

Current Market Cap: $197.7K

Find detailed analytics on TCBPY stock on TipRanks’ Stock Analysis page.